跳至主要内容
临床试验/IRCT20140817018828N6
IRCT20140817018828N6已完成3 期

Investigating the anti-emetic effect of Rheum ribes L. aqueous extract on breast cancer patients receiving ACT chemotherapy

Yazd University of Medical Sciences0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 80 years(—)
性别
All

入选标准

  • Patients with breast cancer
  • Adriamycin, Cytoxan, Taxol (ACT) chemotherapy regimen
  • The first or second course of chemotherapy
  • Patient's satisfaction

排除标准

  • Patients with other cancer history
  • History of receiving chemotherapy
  • History of seizure and use of anti-convulsant drugs
  • Nausea and vomiting degree 2 or 3 within 24 hours prior to chemotherapy
  • Persistent, moderate or severe nausea
  • Hepatitis or gastrointestinal obstruction and metastasis

研究者

发起方
Yazd University of Medical Sciences

相似试验